Watervein Partners
Watervein Partners is a venture capital firm based in Tokyo, Japan, established in 2002. The firm specializes in venture formation, focusing on selecting innovative biotech researchers from universities, research institutes, and industry networks. Watervein Partners provides comprehensive support throughout the startup process, aiming to transform these ventures into successful businesses. The firm adopts a hands-on investment approach, maintaining partial control while guiding companies toward profitable exits through initial public offerings or mergers and acquisitions. By concentrating on seed-stage investments, Watervein Partners seeks to foster the development of first-class enterprises in the biotechnology sector.
Anaeropharma Science
Seed Round in 2007
Anaeropharma Science, Inc. is a biopharmaceutical company based in Chiyoda, Japan, founded in 2004. The company specializes in developing therapeutics aimed at treating solid cancers characterized by hypoxic environments. Utilizing its proprietary platform technology, which involves recombinant Bifidobacterium, Anaeropharma has created innovative therapies such as APS001F, an anticancer solution, and FGF2, which addresses ischemia. Its approach involves genetically enhanced bacteria that thrive in the oxygen-deprived areas of tumors, where they convert a pro-drug into a cytotoxic agent. This technology enables healthcare professionals to provide more effective and safer treatments for various cancers and related hypoxic conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.